Peptides for Sleep

5 research peptides are currently studied for sleep. This guide ranks them by evidence strength and covers their mechanisms, safety profiles, and current clinical status.

Sermorelin, a synthetic peptide comprising 29 amino acids, mimics the natural growth hormone-releasing hormone (GHRH) found in humans. By stimulating the pituitary gland to release endogenous growth hormone, Sermorelin maintains the body's natural feedback mechanisms, potentially reducing the risks associated with exogenous growth hormone therapies. The pivotal study published in the Journal of Clinical Endocrinology & Metabolism in 1997 provided significant findings, showing that participants experienced notable increases in insulin-like growth factor 1 (IGF-1) levels, improved body composition, and enhanced overall well-being over a five-month period. However, while these results are promising, further research is necessary to fully elucidate the peptide's effects on sleep specifically and to confirm long-term safety and efficacy.

MK-677, also known as Ibutamoren, is a unique non-peptide agonist of the ghrelin receptor that promotes growth hormone release without the need for injections. Its oral bioavailability allows for convenient administration and results in sustained elevations of growth hormone and IGF-1 levels for up to 24 hours. Clinical trials have indicated that MK-677 may enhance sleep quality, particularly by increasing slow-wave sleep, which is critical for restorative processes. Despite the encouraging evidence from Phase I and II trials, the long-term implications of MK-677 use on sleep and metabolic health require further investigation to establish comprehensive safety and efficacy profiles.

N-Acetyl Selank Amidate is a derivative of the anxiolytic peptide Selank, modified to enhance its metabolic stability and efficacy. While Selank has received approval in Russia for the treatment of anxiety and cognitive disorders, the amidated form is gaining traction in research settings, particularly for its potential cognitive and anxiolytic effects. Preliminary studies suggest that N-Acetyl Selank Amidate may help reduce anxiety, which can be a contributing factor to sleep disturbances. However, the evidence base remains mixed, with limited human studies available, necessitating further research to clarify its role in sleep modulation and to compare its effectiveness against standard Selank.

Ipamorelin represents one of the most selective growth hormone secretagogues available, engineered as a synthetic pentapeptide. It specifically stimulates the pituitary gland to release growth hormone while minimizing effects on cortisol and prolactin levels, making it an attractive candidate for research into body composition and metabolic health. Preclinical studies indicate that Ipamorelin may enhance growth hormone levels, which could have implications for sleep quality, although direct evidence linking Ipamorelin to improved sleep outcomes is currently lacking. As research progresses, its potential role in sleep regulation will need to be explored more comprehensively.

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide first identified in rabbit brains in 1977. It has garnered interest for its purported ability to induce delta sleep, characterized by slow-wave EEG patterns, which are essential for restorative sleep. DSIP is thought to interact with various neuroendocrine systems, including GABAergic and glutamatergic pathways, as well as the hypothalamic-pituitary-adrenal (HPA) axis, influencing cortisol levels. Although some early European studies have suggested potential benefits for insomnia and stress-related sleep disturbances, the overall evidence remains inconsistent. Further research is needed to clarify its mechanisms and establish a clearer understanding of its efficacy in promoting sleep.